Pharmaceuticals

Battery defect in St Jude’s heart defibrillators causes 2 deaths

13 Oct 2016

Piramal Enterprises to buy five injectable products from Janssen NV

10 Oct 2016

NPPA caps prices of 31 essential drugs

10 Oct 2016

From Edison to miniLab, but scepticism still surrounds Theranos

10 Oct 2016

Novartis to take on Pfizer’s Ibrance with Ribociclib for breast cancer

10 Oct 2016

Mylan to pay $465 mn to settle DoJ probe over EpiPen costs

08 Oct 2016

Generic and specialty pharmaceuticals company Mylan NV yesterday agreed to pay $465 million to settle allegations of overcharging the US government on its Medicaid program for its EpiPen products

Pfizer to sell global infusion therapy business to ICU Medical for $1 bn

07 Oct 2016

Theranos to close labs, wellness centers, focus on ‘minilab’

06 Oct 2016

Intas to buy Teva's UK, Ireland generics business for Rs5,083 cr

06 Oct 2016

J&J warns of hack flaw in insulin pump, calls risk ‘extremely low’

06 Oct 2016

Johnson & Johnson is warning patients that it has learned of a security vulnerability in one of its insulin pumps that a hacker could exploit to overdose diabetic patients with insulin